Priority Date: 21.02.07 (US 20070902949P)

Peptide vaccines with Seq Id No: 110, 111, 387, 112, 394 114, 116, 117 or 121 for cancers expressing tumor-associated antigens

  • Application ID: EP12175489
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This EP application has the IPC combination A61, C07, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 52 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 21.02.2007 - Priority Date (US 20070902949P)
  • 22.05.2013 - Publication A2 (EP2594582)
  • 14.08.2013 - Publication A3 (EP2594582)